VetStem Biopharma is proud to announce that 10 of its most experienced veterinary clients have treated over 100 patients with the VetStem Cell Therapy

June

VetStem Biopharma., reaches milestone- announces that its regenerative stem cell therapy has been used on more than 12,000 animals

July

VetStem Biopharma, Inc. Founder and CEO, Dr. Robert Harman, speaks One Health Innovations – The Nexus of Human and Animal Medicine symposium

August

VetStem Biopharma issued patent that covers methods for extracting/preparing and using adipose tissue-derived stem cells for musculoskeletal injury in any mammal, including humans

October

VetStem Biopharma, Inc., announces publishing of landmark peer-reviewed manuscript on stem cell therapy of canine osteoarthritis. The placebo-controlled study of allogeneic adipose stem cell therapy in dogs with clinical arthritis is the largest study of its kind to date in the veterinary literature

November

2015

April

Vet-Stem Inc, formally changes its name to VetStem Biopharma, Inc.
VetStem completes cGMP manufacturing facility- the first veterinary exclusive stem cell manufacturing facility in the US- to be used for allogeneic stem-cell product development program
VetStem reaches milestone by having processed more than 11,000 samples of its regenerative stem cell therapy

July

VetStem Biopharma announced the successful completion of a field clinical study of its canine osteoarthritis stem cell product, currently under formal development for FDA approval. The product is being co-developed with Aratana Therapeutics (Kansas City, MO) and will be marketed in the US by Aratana. This product, termed AT-016, is an allogeneic adipose stem cell product for the treatment of osteoarthritis in the dog. The formal FDA Investigational New Drug Application was filed in 2011.

August

Dr Robert Harman, Founder and CEO of Regenerative Veterinary Medicine company VetStem Biopharma, Inc. speaks at MSC 2015 Innovations in Cell-Based Regenerative Therapies

September

VetStem CEO, Dr. Robert Harman, presents at the 2015 Kansas City Animal Health Investment Forum
VetStem Biopharma launches two new Clinical Research program for Equine Cervical Facet joint disease and Equine Exercise-Induced Pulmonary Hemorrhage

November

2014

January

Milestone: Ten years, 10,000 animals!
FEMA Urban Search and Rescue canine of Ohio Task Force 1 receives stem cell therapy by Vet-Stem so he can continue to save lives.
San Diego 6 News features Vet-Stem in Laura Cavanaugh’s story about canine therapies.
Vet-Stem, Inc. Proudly Sponsors the Regenerative Medicine Sessions at the Fourth World Veterinary Orthopaedic Congress

February

Petplan Pet Insurance and Vet-Stem work together to bring stem cells to pets nationwide.

April

Vet-Stem announces a non-exclusive European license agreement has been signed with a global human stem cell company for Vet-Stem’s new patent regarding extraction methods and use of adipose-derived stem cells in prevention and treatment of diseases in the human.
Stem Cells Discovery publishes “Single-Center Study of 83 Horses with Suspensory Injuries Treated with Adipose-Derived Stem and Regenerative Cells” by Dr. Ross Rich who has treated over 600 horses using Vet-Stem Cell Therapy

May

Vet-Stem patent for stem cells covers human sports medicine applications for New Zealand, covering methods for extracting/preparing and using adipose-derived stem cells for preventing or treating diseases in any mammal, including humans.

June

July

Landmark Licensing Deal in Regenerative Veterinary Medicine a First as Vet-Stem Selects Aratana as Partner to Commercialize Canine Osteoarthritis Stem Cell Product
Arizona Pet Vet Family of Animal Hospitals hosts Vet-Stem, Inc. for a summer session of RACE approved Credentialing Courses and wet-labs on stem cell therapy
WABC Radio show out of New York City, A “Paws” For Your Pet with Lorry Young hosts California-based Vet-Stem, Inc.’s Founder and CEO, Robert J. Harman, DVM, to talk about stem cell therapy in pets.

August

Vet-Stem starts an investigational study of stem cells for dogs with arthritis, using an allogenic (donor) product- one in a series of studies aimed at receiving an FDA approved allogenic “off the shelf” stem cell treatment for dogs

2013

February

Vet-Stem updates the RACE approved Continued Education course for small animal stem cell therapy.

March

Robert Harman, DVM, Founder of Vet-Stem, Inc. and CEO presents Stem Cell Therapy in Veterinary Dermatology at the International Veterinary Dermatology Conference.

June

Vet-Stem, Inc. iPad App is brought to market as a sales tool for veterinarians and animal hospital staff, highlighting video of stem cell success stories.

July

Former COO and CSO of IDEXX Laboratories, Inc., Erwin Workman, Jr., joins Board of Directors for Vet-Stem, Inc.
Dr. Bob Harman presents at the 6th Annual Business Education Course The Business of Regenerative Medicine: From Stem Cells to the Market Place making it his 12th time speaking at Case Western Reserve University.

August

Dr. Bob Harman is invited as Inspirational Speaker for the 6th Annual After the Finish Line Charity Dinner.
Vet-Stem, Inc. partners with The Veterinary Cooperative to bring regenerative cell therapies to a larger network of small animal veterinarians and animal hospitals nationwide.
Vet-Stem, Inc. Founder and CEO, Robert Harman, DVM, Invited to Speak at the Adult Stem Cell Therapy and Regenerative Medicine Conference
CBS 5 AZ (KPHO-TV) features Dr. Ross Rich and Cave Creek Equine Surgical and Diagnostic Imaging Center regarding Vet-Stem Regenerative Cell Therapy and performance horses.

September

Arizona Pet Vet partners with Vet-Stem to bring Regenerative Cell Therapies to their pet patients, and hosts a week of veterinary stem cell credentialing, technician training, and wet-labs.

October

November

Dr. Ross Rich presents the Outcome of 42 Horses with Stifle Injuries Treated with Adipose-Derived Regenerative Cells & IRAP, and Dr. Bob Harman presents a talk entitled One Medicine and Collaboration for Rapid Development of Cell Therapy at the 3rd North American Veterinary Regenerative Medicine Association conference.

December

2012

January

Milestone: Vet-Stem, Inc. achieves over 8,000 veterinary stem cell cases with over half of those being horse.
Vet-Stem and Dr. Sherman Canapp present at the 28th International Canine Sports Medicine Symposium about Regenerative Medicine for Canine Sports Related Injuries.

February

Dr. Bob Harman invited speaker on Feline Chronic Kidney Disease at AMC Advanced Renal Week.

March

StemInsure is launched as a way for dog owners to bank a small number of stem cells for future culture and use, similar to umbilical cord blood storage for humans.

April

A new patent for Cartilage Repair Issues is created under Vet-Stem Stem Cell License.
Dr. Kathy Fitzwater and Dr. JoAnne Roesner present three hours of stem cell science and data using Vet-Stem data at American Board of Veterinary Practitioners 17th Annual Symposium.

May

Stem Cells and Development publishes “Adipose-Derived Stem Cell Collection and Characterization in Bottlenose Dolphins” presenting data obtained from the collaboration between the National Marine Mammal Foundation and Vet-Stem.

November

Pets Best Insurance Announces Stem Cell Therapy and Regenerative Veterinary Medicine by Vet-Stem, Inc. Covered by Their Pet Health Insurance.

December

Vet-Stem, Inc. hosts Stem Cell Boot Camp in partnership with Peak Performance Veterinary Group of Colorado Springs, and Dr. James Gaynor.

2011

January

Milestone: Vet-Stem celebrates the New Year with the of 3,000th treatment of a canine companion Vet-Stem cell therapy.
Harrison Perrin and her horse “Win a Kitty,” who was treated with Vet-Stem Regenerative Stem Cell Therapy, won the $100,000 5/6-Year-Old Amateur Championship of the Augusta Classic.

February

Dr. Marty Becker, known as America’s Veterinarian and a frequent guest on Good Morning America, launches Vet-Stem Cell therapy at his clinic in Idaho.

April

Vet-Stem is one of a select group of sponsors for the Dr. Marty Becker Big Bus Tour which travels to 29 cities in the US educating veterinarians and dog owners about dog health and veterinary stem cell therapy.

May

The first public presentation on stem cell isolation from dolphins was given by Dr. Shawn Johnson at the International Association for Aquatic Animal Medicine in Las Vegas, with information obtained from a funded three-year collaboration between the National Marine Mammal Foundation and Vet-Stem, Inc. to assess the regenerative capacity in bottlenose dolphins.

June

Vet-Stem partners with Dr. James Gaynor and Peak Performance Veterinary Group to sponsor the Pet Evaluation Trailer, which provides mobile diagnostic services for.
Corey Orava, DVM, Veterinary Services Manager at Vet-Stem, presents Immunomodulation: A Review with a Focus on T-Cells at American College of Veterinary Internal Medicine Forum in New Orleans, Louisiana.
Dr. Natanya Nieman speaks about using hyperbaric oxygen therapy and Vet-Stem Cell Therapy for horses, and Dr. Keith Clement presents data on 34 dogs treated for osteoarthritis with Vet-Stem Cell Therapy with greater than 88% showing improvement in quality-of-life, at the 2nd annual North American Veterinary Regenerative Medicine Association Conference.

July

Vet-Stem, Inc. hosts six speakers and eight hours of stem cell educational symposium at the annual AVMA.
Dr Ross Rich presents Seven Years` Experience Using Adipose-Derived Stem Cells for Treatment of Orthopedic Injuries in the Horse at Pacific Veterinary Conference. Dr. Rich had treated over 400 equine patients with Vet-Stem Regenerative Cell Therapy since 2004.

September

The Tallahassee Museum’s male Florida panther receives Vet-Stem regenerative cell therapy in his right elbow.

November

USDF Region 5 Championship honors Fontainebleau in a retirement ceremony celebrating his many accomplishments after Vet-Stem Cell Therapy helped him return to competition. These accomplishments include 2008 USDF Grand Prix Region 5 Championship, 2009 winner of the Mustang Smackdown, 2009 Del Mar Grand Prix 3rd place CDI Freestyle, 2009 National Dressage Championships in Gladstone, and Prix St. George at CDI Rancho Murrieta.

December

Dr. Peter Vogel publishes “Making Sense of Stem Cells for Companion Animals” in The Pulse Magazine using Vet-Stem data.

2010

January

The North American Veterinary Conference (NAVC), the American Animal Hospital Association (AAHA), the Western Veterinary Conference and the Atlantic Coast Veterinary Conference (ACVC) invite Vet-Stem to provide on-site regenerative stem cell therapy training for veterinary conference attendees in 2010.
Networking with our credentialed veterinarians and pet owners, Vet-Stem begins a fan page on Facebook.

February

Fox News features Behr, a young German Shepherd plagued by arthritis pain from hip dysplasia who was successfully treated with Vet-Stem Regenerative Cell Therapy.
Over 1,400 owners bank on the future by storing therapeutic doses for their pet.

March

BBC Radio: Dr. Bob Harman is interviewed about the benefits of stem cells.
Dr. Martin Gardner presents data on 116 cases of proximal suspensory desmitis treated with Vet-Stem Cell Therapy showing greater than 90% of cases returning to full work.
Three major pet insurance companies approve the benefits of Vet-Stem Regenerative Stem Cell Therapy as a treatment option for their clients: Petplan, VPI Pet Insurance, and PurinaCare Pet Health Insurance.

April

FoxTV features the Vet-Stem Regenerative Cell Therapy story of Lucky, a Chocolate Labrador Retriever.

May

Vet-Stem reaches over 1,200 fans on Facebook and can now be followed on Twitter.

June

Vet-Stem signs an exclusive license with Chemaphor, a Prince Edward Island based animal therapeutics company, allowing veterinarians throughout Canada to provide fat-derived stem cell therapy to horses, dogs and cats.
Milestone: Over 3,600 horses and 2,500 dogs treated with Vet-Stem Regenerative Cell Therapy

August

Ohio State University invites Vet-Stem to speak provide on-site regenerative stem cell credentialing course as part of their veterinary continuing education program.

September

Dr. Robert Harman, DVM, MPVM, CEO of Vet-Stem, presents a talk entitled “Stem Cell Therapy: Mechanisms of Action” at the Annual Research Symposium of the American College of Veterinary Surgeons (ACVS) in Seattle.

November

Vet-Stem provides free lifetime stem cell supply to Lex, the military canine hero.
Feedback from owners of young dogs indicates that 84% of young dogs with arthritis have an improved quality of life after Vet-Stem Cell therapy.

December

Vet-Stem achieves a milestone of 4,000 horses treated with Vet-Stem cell therapy.

2009

January

Nightline features Vet-Stem services for dogs suffering from arthritis pain due to hip dysplasia. Hunter, a Golden Retriever faced with a potential hip replacement, demonstrates the benefits of stem cells in reducing pain.

May

Vet-Stem employees raise over $2,000 for the ASPCA in a local Southern California walk-a-thon.

July

Vet-Stem offers Culture, a service expanding the supply of stem cells for the animal’s lifetime.
Results from a voluntary survey of dog owners indicate that at 90 and 246 days after Vet-Stem treatment, more than 62% of dogs with osteoarthritis discontinued or decreased the use of non-steroidal anti-inflammatory (NSAID) drugs after stem cell therapy.

August

Owner evaluations report that for orthopedic conditions greater than 80% of their dogs treated with fat-derived stem cells showed an improvement in quality of life and 85% of dog owners would recommend Vet-Stem Regenerative Cell Therapy to others.
U.S. Navy, Office of Naval Research, awards a contract to Vet-Stem to engage in a collaborative study of stem cell biology in marine mammals.

October

Vet-Stem launches a blog on blog.vetstem.com as a portal to answer frequently asked questions about arthritis and other dog health issues.

November

Dr. Bob Harman, Vet-Stem CEO, speaks at the first annual Cell Therapy Summit Meeting (Human) as a Point of Care stem cell therapy expert.

December

Milestone: Over 2,000 dogs and 3,300 horses have been treated with Vet-Stem Regenerative Cell Therapy.

2008

January

Vet-Stem’s Small Animal Online Training Program launches on the East Coast at the North American Veterinary Conference in Orlando, Florida.

February

USA Today features Maggie, a German Shepherd, offering hope through Vet-Stem Regenerative Cell Therapy for pets dogged with pain.
Vet-Stem is invited to instruct a Small Animal Credentialing Course at The Western Veterinary Conference in Las Vegas.

July

TIME Magazine features Blue, a German Shepherd, in an article on stem cell therapy for pets after being treated with Vet-Stem Regenerative Cell Therapy.
Cornell researchers publish a study on the effects of adipose-derived stem cells on tendon repair in horses. Histological evaluation revealed a significant improvement in tendon fiber architecture; reduction in vascularity, inflammatory cell infiltrate, and collagen type III formation; and improvements in tendon fiber density and alignment in tendons treated with Vet-Stem Regenerative Cell Therapy.

September

Veterinary Therapeutics publishes a peer reviewed study on the use of stem cells for treatment of chronic osteoarthritis in the elbow of dogs. This clinical trial reports a significant improvement in lameness, range of motion, and functional ability in dogs treated with Vet-Stem Regenerative Cell Therapy.

October

Milestone: 3,000 horses have been treated with Vet-Stem Regenerative Cell Therapy, and 9 months after launching Small Animal applications over 1,000 dogs have been treated for orthopedic conditions.

2007

May

Vet-Stem secures exclusive worldwide rights to the Emcyte Genesis blood platelet concentrating system (Platelet Rich Plasma, PRP) for providing growth factor therapy in animals.
Vet-Stem conducts the first formal Small Animal Credentialing Course for California Board Certified Surgeons at a workshop in San Diego, California.

August

Milestone: 2,000 horses have been treated with Vet-Stem Regenerative Cell Therapy.

September

Vet-Stem signs an exclusive license to the Central Veterinary Research Labs (CVRL) of Dubai, United Arab Emirates. This gives CVRL the rights to provide fat-derived stem and regenerative cells to veterinarians throughout the Middle East region.
Newsweek features Nakota, a Siberian Husky, on the road to recovery after Vet-Stem Regenerative Cell Therapy.

November

The first randomized double-blinded placebo controlled multi-centered study is published showing that intra-articular injection of fat derived stem cells into the hip joint of the dog decreases patient discomfort and increases patient functional ability.

2006

April

Milestone: Vet-Stem is the first company to provide regenerative stem cell services for 1,000 animals.
The first cat is treated with Vet-Stem Regenerative Cell Therapy.

September

Vet-Stem secures additional exclusive worldwide veterinary rights from the University of California for fat-derived stem cells.

November

Vet-Stem hosts the grand opening of new laboratories in Poway, California with expansion to over three times its prior laboratory space.

2005

September

Milestone: 500 horses have been treated with Vet-Stem Regenerative Cell Therapy.

2004

January

Vet-Stem introduces the first veterinary stem cell service in the United States.
The first horse is treated with Vet-Stem Regenerative Cell Therapy.

October

Vet-Stem secures exclusive worldwide veterinary rights for equine umbilical cord stem cell technology from Kansas State University.

November

Vet-Stem signs an agreement with Cognate Therapeutics, a leader in human stem cell technology, for the further development of stem cell therapy for use in veterinary medicine.
The first dog is treated with Vet-Stem Regenerative Cell Therapy.

2003

October

Vet-Stem signs a worldwide exclusive license for fat-derived stem cell technology for veterinary applications.

2002

October

Vet-Stem founded.

Virtual Tour of VetStem Laboratories - Video